chronic prostatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18 to 50 years; 2) with typical symptoms of chronic prostatitis type IIIB (different levels of urinary tract irritation and pelvic discomfort); 3) NIH-CPSI score >=15 points; 4) The disease history is more than 3 months; 5) B-ultrasound examination: the prostate size is normal; 6) tPSA<4ng/ml; 7) Prostatic fluid conventional white blood cells <10/HP.
Exclusion criteria
Exclusion criteria: 1) Patients with benign prostatic hyperplasia; 2) History of neurological lesions (such as neurogenic bladder dysfunction); 3) Suspected prostate cancer, urethral tumor or bladder cancer; 4) Those who have had a history of prostate surgery or invasive treatment (such as balloon angioplasty, transurethral microwave thermotherapy, urethral stent implantation, etc.); 5) Those who have had urethral stricture or deformity in the past; 6) Acute urinary tract infections; 7) The lower ureter stones; 8) Severe heart, liver and kidney dysfunction; 9) Testicular epididymis and spermatic cord disease; 10) Allergic or allergic to the ingredients of this product; 11) Taking other drugs that affect the trial within the last 3 months; 12) Those who cannot understand or fail to complete the trial and who have no legal capacity or self-awareness; 13) Those who participate in other clinical drug trials at the same time; 14) There are other factors that may affect the results of this test or may not be appropriate for the tester based on the investigator's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prostate fluid WBC count and lecithin corpuscle count; | — |
Countries
China
Contacts
Changhai Hospital